In particular, schistosome specific IgE and IgA are commonly associated with protection against re‐infection after PZQ treatment in humans.40, 41, 42 Ideally, vaccination programs would be the most effective control strategy for schistosomiasis. The gene discussed is CD79A; the disease is schistosomiasis.